Beijing Dongfang Biotech Co., Ltd.
Clinical trials sponsored by Beijing Dongfang Biotech Co., Ltd., explained in plain language.
-
New diabetes injection trial aims to outperform current treatment
Disease control OngoingThis study is testing whether a new medication called JY09 works better than an existing drug (dulaglutide) for people with type 2 diabetes whose blood sugar isn't well controlled with metformin alone. About 600 participants will receive either JY09 at one of two doses or dulaglu…
Phase: PHASE3 • Sponsor: Beijing Dongfang Biotech Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 09:11 UTC
-
New diabetes drug seeks to lower blood sugar Long-Term
Disease control OngoingThis study is testing whether a new injectable drug called JY09 is safe and effective at lowering blood sugar in adults with type 2 diabetes. It will involve 270 people whose diabetes is not well managed by diet and exercise alone. Participants will receive either JY09 or a place…
Phase: PHASE3 • Sponsor: Beijing Dongfang Biotech Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC